510(k) device
P200TE (A10700)
Optos Plc. · Tomography, Optical Coherence (OBO, Class II) · First FDA decision Aug 18, 2023, newest May 9, 2024GlaucomaMacular degeneration and retinal disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
10
Naming "P200TE"
MAUDE reports
0
Brand "P200TE", since 2015
PubMed studies
0
Mentioning "P200TE"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- P200TE (A10700)510(k)
K233602 · Decided May 9, 2024 · 182 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
- P200TE (A10700)510(k)
K231673 · Decided Aug 18, 2023 · 71 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "P200TE", any status and sponsor, newest update first.
- Modified P200TE Data CollectionRecruiting
Optos, PLCNot on our public-company list
NCT07796230 · 50 participants (planned) · Start Jul 29, 2026 · Primary completion Oct 1, 2026
Device: imaging device · For: Retina Disease
Sites: Louisville, Kentucky
- P200TE US Reference Database StudyCompleted
Optos, PLCNot on our public-company list
NCT05844852 · 954 participants · Start Mar 14, 2023 · Primary completion Sep 13, 2023
Device: P200TE · For: Normal Eyes
Sites: Anaheim, California; San Diego, California; Venice, Florida · 9 sites in all
- Glaucoma Evaluation With the P200TECompleted
Optos, PLCNot on our public-company list
NCT06305481 · 53 participants · Start Feb 13, 2024 · Primary completion Oct 23, 2024
Device: P200TE · For: Glaucoma
Sites: Cajon, California; Bellevue, Washington
Optos, PLCNot on our public-company list
NCT05615896 · 5 participants · Start Apr 22, 2021 · Primary completion Apr 28, 2021
Device: Imaging Session · For: Retinal Disease
Sites: Houston, Texas
- P200TE and Predicate Agreement and Precision StudyStatus unknown
Optos, PLCNot on our public-company list
NCT05624593 · 125 participants (planned) · Start Nov 4, 2022 · Primary completion Mar 2023
Device: P200TE; Predicate · For: Normal; Retina Disease; Glaucoma
Sites: Chicago, Illinois
- P200TE Agreement and Precision StudyTerminated
Optos, PLCNot on our public-company list
NCT05536401 · 15 participants · Start Sep 2, 2022 · Primary completion Sep 20, 2022
Device: P200TE; Predicate Device · For: Retina Disease; Glaucoma; Normal
Sites: Chicago, Illinois
Optos, PLCNot on our public-company list
NCT03912584 · 10 participants · Start Apr 29, 2019 · Primary completion Apr 30, 2019
Device: P200TE; P200TxE · For: Glaucoma
Sites: San Antonio, Texas
Optos, PLCNot on our public-company list
NCT03783858 · 356 participants · Start May 30, 2019 · Primary completion Oct 8, 2019
Device: P200TE · For: Healthy
Sites: Bedford, United Kingdom; London, United Kingdom; Belfast, United Kingdom · 5 sites in all
Optos, PLCNot on our public-company list
NCT03868462 · 137 participants · Start Feb 11, 2019 · Primary completion Sep 16, 2019
Device: Optos P200TE; Predicate Device · For: Retinal Disease; Glaucoma
Sites: Springfield, Massachusetts
Optos, PLCNot on our public-company list
NCT02921568 · 20 participants (planned) · Start Sep 2016 · Primary completion Dec 2017
Device: P200TE; Spectral OCT/SLO · For: Retinal Disease; Glaucoma
Sites: San Antonio, Texas
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "P200TE", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OBO
13 reports: 4 malfunction, 9 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "P200TE"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code OBO.
- SPECTRALIS HRA+OCT and variantsHeidelberg Engineering GmbH · 510(k) 2026
- CIRRUS HD-OCT Model 6000Carl Zeiss Meditec, Inc. · 510(k) 2024
- AnterionHeidelberg Engineering GmbH · 510(k) 2026
- Spectralis HRA + OCT and variantsHeidelberg Engineering GmbH · 510(k) 2018
- 3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1 (type: Maestro2)Topcon Corporation · 510(k) 2024
- Tomey Cornea/Anterior Segment OCT (CASIA2)Tomey Corporation · 510(k) 2025
- RESCAN 700, CALLISTO eyeCarl Zeiss Meditec, AG · 510(k) 2019
- iVueOptovue, Inc. · 510(k) 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.